Abstract
To investigate the potential use of E. coli cytosine deaminase (CD) gene instead of the commonly used HSV-TK gene in the gene therapy of brain tumors, we constructed a retrovirus vector carrying the CD gene. We then transduced a rat glioma cell line C6 with CD gene by the retrovirus vector. Transduction of the CD gene made C6 cells become highly sensitive to the anti-fungi drug 5-fluorocytosine (5FC). IC50 for 5FC was 6,000 microM in CD-negative cells, while it was 3 microM in CD-positive cells. Mixed cellular assay showed that CD-positive cells had a strong "bystander effect" on CD-negative cells when exposed to 5FC. Significant anti-tumor effects were observed in nude mice bearing s.c. tumors derived from CD-positive cells when these animals were given 250 mg/kg 5FC twice a day for 20 consecutive days. A marked decrease in tumor weight occurred when a mixture containing 50% CD-positive and 50% CD-negative C6 cells was injected s.c., followed by 5FC treatment, suggesting the bystander effect in vivo. Concerning the pharmacokinetics of 5FC, especially its high oral bio-availability and good penetration into cerebrospinal fluid, we suppose that the combination of CD-gene transfer and 5FC oral administration may have potential us...Continue Reading
References
Sep 1, 1978·Clinical Pharmacology and Therapeutics·R E CutlerM R Kelly
Jun 12, 1992·Science·K W CulverR M Blaese
May 1, 1992·Molecular Microbiology·S DanielsenJ Neuhard
Jan 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C A MullenR M Blaese
Jul 26, 1968·Science·P BendaW Sweet
Apr 1, 1971·Annals of Internal Medicine·R J Fass, R L Perkins
Jan 1, 1983·Clinical Pharmacokinetics·T K Daneshmend, D W Warnock
Oct 10, 1980·Nucleic Acids Research·M G Murray, W F Thompson
Aug 1, 1995·Human Gene Therapy·E A HirschowitzR G Crystal
Jan 1, 1995·British Medical Bulletin·H A Jinnah, T Friedmann
Jan 1, 1995·British Medical Bulletin·K W CulverT Seregina
Feb 1, 1994·Molecular Biotechnology·M R EvansD W Harris
Dec 1, 1994·Molecular Biotechnology·R Krumlauf
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·M E BrewsterN Bodor
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·B E HuberS S Good
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·S H ChenS L Woo
Jan 1, 1993·Methods in Enzymology·A D MillerC M Lynch
Feb 1, 1993·Clinical Pharmacokinetics·G D MorseA M O'Donnell
Apr 10, 1996·Human Gene Therapy·Y DongH A Fine
Citations
Dec 15, 2010·Future Oncology·Erik Hp van PuttenMartine Lm Lamfers
Feb 27, 2010·Experimental Cell Research·Yingbin YangK L Paul Sung
Jul 11, 2006·Cancer Science·Takayuki SasakiShun'ichiro Taniguchi
Dec 2, 1999·Journal of the National Cancer Institute·J C Morris
Feb 13, 2009·Pediatric Blood & Cancer·Steven W WarmannUlrich M Lauer
Apr 18, 2002·Cancer Gene Therapy·Juhana M HakumäkiRisto A Kauppinen
May 15, 2002·Archives of Pharmacal Research·Henry J LeeDong-Hoon Ko
Mar 16, 2002·Gene Therapy·W A WybranietzU M Lauer
Jun 29, 2000·Gene Therapy·L D StegmanB D Ross
Mar 10, 2001·Journal of Cellular Physiology·O Greco, G U Dachs
Mar 20, 2002·Anti-cancer Drugs·S NuytsJ Anné
Mar 13, 2014·Journal of Neuro-oncology·Frederick WangHenry Hirschberg
Nov 30, 2019·Neurosurgical Review·Ryota TamuraMasahiro Toda
Mar 17, 2006·Cancer Research·Paul D BoucherDonna S Shewach
Nov 15, 2020·Photodiagnosis and Photodynamic Therapy·Gabrielle RomenaHenry Hirschberg
May 5, 2001·Brain Research. Brain Research Reviews·M Bredel